Today, I am present at the School of Medicine of Padjadjaran University in Bandung to witness the first injection of the vaccine on 1,620 volunteers involved in clinical trialsJakarta (ANTARA) - President Joko Widodo bore witness to clinical trials of the COVID-19 vaccine administered to 1,620 volunteers in Bandung City, West Java, on Tuesday.
"Today, I am present at the School of Medicine of Padjadjaran University in Bandung to witness the first injection of the vaccine on 1,620 volunteers involved in clinical trials," the head of state noted during a videoconference in Bandung on Tuesday.
Widodo is upbeat about the phase III clinical trials of the COVID-19 vaccine being completed in six months' time.
Indonesia is expected to independently produce the vaccine by January 2021. If the vaccine can be produced en masse, it will later be distributed across the Indonesian nation, he noted.
The vaccine, administered to 1,620 volunteers, is developed by state-owned pharmaceutical company PT Bio Farma and Chinese vaccine producer Sinovac.
The president noted that in the past three months, vaccine development was being conducted by the Eijkmam Institute along with the Agency for the Assessment and Application of Technology (BPPT), Indonesian Institute of Sciences (LIPI), Drug and Food Supervisory Board (BPPOM), Research and Technology Ministry, and several universities. Related news: Indonesia currently developing its own Red and White vaccine: Jokowi
Related news: COVID-19 vaccine clinical trials: 21 volunteers undergo swab test
Translator: Rangga Pandu Asmara Jingga/Suh
Editor: Rahmad Nasution
Copyright © ANTARA 2020
